SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Chinese CBD Market In The Sights Of Yooma After £6m EMMAC Deal

    By

    UK cannabis business EMMAC Life Sciences Group has sold its Yooma Wellness business for over $8m with the emerging Chinese wellness market in the sights of its new owners.

    Canadian Securities Exchange-listed Yooma has acquired the Blossom, MYO, Hello Joya and What the Hemp brands which have a strong presence Asia.

    EMMAC and Yooma had previously signed a licensing agreement on the Yooma brands in January this year.

    Ron Wardle, Co-CEO of Yooma, said the deal would allow it to target the fast-growing European market, ‘particularly in the UK where MYO Plant Nutrition‘s supplements are gaining tremendous traction with some national retailers’. 

    Strategic Focus

    He added: ”We also intend to continue our focus on China and rebrand Blossom, with plans to launch in certain Asian markets later this year.”

    Antonio Costanzo, CEO of EMMAC, said: “EMMAC’s strategic focus is to accelerate the growth of its medical cannabis and B2B wellness business operations.” 

    The total purchase price is approximately US$8.1m, and will be payable as 7,459,981 shares of Yooma valued at CA$1.384.

    Yooma is an emerging marketer and distributor of cannabinoid and hemp-derived wellness products. EMMAC is Europe’s largest independent cannabis company, bringing together science and research with ccultivation, extraction and production. 

    It is an investee company of FastForward Innovations Ltd, an AIM quoted company focusing on making investments in cannabis and other fast-growing industries

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Peter

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free